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Introduction
Runt-related (Runx) transcription factor family has the highly conserved Runt DNA binding domain and comprises three members: Runx1, 2, and 3 in mammal. These Runxs play important roles in cell proliferation and differentiation of various cell types, including hematopoietic cells, osteoblasts, and gastric epithelial cells (Komori et al., 1997; Levanon et al., 2001; Wang et al., 1996 ; for reviews, see Coffman, 2003; Ito, 2004 Ito, , 2008 . In addition, the anomaly of Runxs has been shown to be involved in various human diseases (Ito et al., 2005 Li et al., 2002; Otto et al., 1997 ; for reviews, see Ito, 2004 Ito, , 2008 . Runx1 and Runx3 are also expressed in neuronal subtypes in the embryonic nervous systems (Levanon et al., 2001; Simeone et al., 1995 ; for reviews, see Inoue et al., 2008; Stifani and Ma, 2009 ).
In the dorsal root ganglion (DRG), Runx1 and Runx3 are expressed in a subpopulation of sensory neurons and control the cell fate specification and the axonal projections of nociceptive and proprioceptive DRG neurons, respectively (Chen et al., 2006a, b; Inoue et al., 2002 Inoue et al., , 2007 Kramer et al., 2006; Levanon et al., 2002; Marmigère et al., 2006; Nakamura et al., 2008; Yoshikawa et al., 2007 ; for reviews, see Inoue et al., 2008; Marmigère and Ernfors, 2007; Stifani and Ma, 2009 ). In particular, Runx1 is initially expressed in nerve growth factor (NGF) receptor TrkA-expressing (TrkA + ) neurons from the early developing period, and is involved in the segregation of these neurons into TrkA + /calcitonin gene-related peptide (CGRP) + peptidergic nociceptive neurons and Runx1 + /glial cell-derived neurotrophic factor (GDNF) receptor Ret + nonpeptidergic nociceptive neurons by inhibiting the expression of
TrkA and CGRP and promoting the Ret expression in DRG neurons from the late embryonic to postnatal period (Chen et al., 2006b; Kramer et al., 2006; Marmigère et al., 2006; Yoshikawa et al., 2007) .
In the nasal cavity, Runx1 is expressed in proliferating cells in the olfactory epithelium.
Runx1 deficiency reduces proliferation and causes premature differentiation of olfactory receptor neuron (ORN) precursors, suggesting that Runx1 coordinates the proliferation and differentiation of ORN precursors (Theriault et al., 2005) . In DRG, proliferation of presumptive neurons occurs for several days around E12.5 in the lumbar segments (Lawson and Biscoe, 1979) , while Runx1 expression begins in the same segments as early as E12.5 (Chen et al., 2006b) , showing the overlap between the cell proliferation and the onset of Runx1 expression in DRG. We have previously shown that Runx1 inhibits proliferation of DRG cells between E11.5 and E13.5, although we did not characterize proliferating cell types as neuronal or non-neuronal cells (Yoshikawa et al., 2007) . These results suggest that Runx1 has another roles in the proliferation and differentiation of DRG neurons during the early developmental stage, in addition to the subtype specification of nociceptive DRG neurons in the late developmental period.
In the present study, to elucidate roles of Runx1 in the early stage of DRG neuron differentiation, we analyzed the proliferation and the cell fates of DRG neuron in Runx1 deficient mice. (Fig. 1C , F, and G, Table1). There was no significant difference in the number of TrkC + DRG neurons between the two genotypes at E12.5 ( Fig. 1H -J, Table1).
Results

Transient decrease of DRG neurons in
Next, we examined whether the loss of Runx1 affects the total number of DRG neurons from E11.5 to E13.5, using NeuN as a pan-neuronal marker (Fig. 2, Table1 ). ::Tg mice (Fig. 2B , E, and G, Table1), and 90% at E13.5 (Fig. 2C , F, and G, Table1). Because the decrease in the number of NeuN + DRG neurons at E12.5 and E13.5 may be due to the reduction of total DRG cells, we examined the number of total DRG cells using DAPI and the volume of DRG at E12.5
( Fig. 3A-D 
Runx1
-/-::Tg mice (45.9 ± 2.1 × 10 5 µm 3 ) at E12.5 (Fig. 3D) . Moreover, to clarify whether the effects of Runx1 deficiency on the apoptosis of DRG, we examined the number of caspase3 + DRG cells at E11.5 and E12.5 ( Fig. 3E-I (Fig. 5F ). These results suggest that Runx1 suppresses the DRG cell proliferation without effects on the length of S-phase.
Increase of Hes1 + DRG cells in Runx1
-/-∷Tg mice
To gain further insight into the roles of Runx1 in the differentiation of DRG neurons, we focused on a basic helix-loop-helix protein Hes1, because Hes1 has been shown to inhibit neuronal differentiation (Cau et al., 2000; Ishibashi et al., 1995; Tomita et el., 1996 
Discussion
In the present study, we examined the roles of Runx1 in the proliferation and differentiation of DRG neurons during the early embryonic period. We found that the Runx1 deficiency decreased the number of DRG neurons which express TrkA and three neuronal markers, Hu, NeuN, and Islet1, while the number of DAPI + total DRG cells and caspase3 + apoptotic cells
was not changed at E12.5. In addition, we showed that Runx1 deficiency increased both proliferating DRG cells and Hes1 expression in DRG. Taken together, it was suggested that Runx1 promotes the DRG neuronal differentiation by suppressing Hes1 expression at restricted time window in the early developmental stage.
Roles of Runx1 in the cell proliferation and neuronal differentiation at early stage of DRG development
It was reported that Runx1 is initially expressed in TrkA + DRG neurons and subsequently segregates these neurons into Runx1 + /Ret + nonpeptidergic nociceptive neurons and TrkA + /CGRP + peptidergic nociceptive neurons by repressing the expression of TrkA and CGRP and activating c-Ret expression from the late embryonic through postnatal period (Chen et al., 2006b; Kramer et al., 2006; Marmigère et al., 2006; Yoshikawa et al., 2007) .
Although Runx1 plays crucial roles in the diversification of nociceptive DRG neurons from the late embryonic period, Runx1 is expressed as early as E12.5 (Chen et al., 2006b , Fig. S1 ), when there are many proliferating cells in DRG (Lawson and Biscoe, 1979) . In addition, we have previously shown that Runx1 deficiency increased the proliferation of DRG cells during E11.5 and E13.5 (Yoshikawa et al., 2007) . Taken together, these results suggest that Runx1 may be involved in the proliferation and/or differentiation of DRG neurons at early embryonic stage.
The present study revealed that the number of DRG neurons which express Hu, NeuN, Islet1, or TrkA was decreased in Runx1-deficient mice at E12.5, independent of the DAPI + total cell number and the caspase3 + apoptotic cells. Hu is a RNA-binding protein expressed during neurogenesis and promotes neuronal differentiation (Akamatsu et al., 2005; Wakamatsu et al., 1997) . NeuN is a pan-neuronal marker expressed in differentiated neuron, and Islet1 is a transcription factor expressed in the process of neuronal specification of selected neurons including DRG neurons (Avivi et al., 1999) . Considering the characteristics of these molecules, the present findings suggest that Runx1 is involved in promoting neuronal differentiation from the early stages of the neurogenesis. In addition, the cell cycle analysis suggested that Runx1 decreases the proliferation of DRG cells without changes in cell cycle length. Taken together, these results suggest that Runx1 has a role in suppressing the proliferation of DRG cells and promoting DRG neuronal differentiation.
In the present study, TrkA + and NeuN + neurons were decreased transiently at E12.5 but not E11.5 in Runx1 -/-::Tg DRG. The failure of effects of Runx1 deficiency at E11.5 seems to be due to the insufficient expression of Runx1 to cause significant changes in the number of TrkA + and NeuN + DRG neurons, because it was reported that Runx1 expression does not begin until E12.5 in DRG (Chen et al., 2006b ). We previously reported that the number of TrkA + neurons was increased in Runx1 -/-::Tg DRG at E17.5 (Yoshikawa et al., 2007) . This effect was explained by the suppression of TrkA expression by Runx1 (Chen et al., 2006b; Yoshikawa et al., 2007) . In contrast, the present study showed the contradictory results that the number of TrkA + neurons was reduced in Runx1 -/-::Tg at E12.5. There seem to be at least two possibilities for the early decrease of TrkA + neurons. First, Runx1 deficiency suppresses the DRG neuronal differentiation, which subsequently results in the reduction of the number of TrkA + neurons at E12.5. In this case, Runx1 is not necessarily involved in the direct regulation of TrkA expression. This is highly possible considering that TrkA is expressed in postmitotic neurons committed to a sensory neuronal fate (Marmigère and Ernfors, 2007) .
The second possibility is that Runx1 induces the TrkA expression directly. In accordance with the second possibility, it was reported that overexpression of Runx1 induces precocious TrkA expression in migrating neural crest cells without promoting neuronal differentiation, and that the number of TrkA + DRG neurons is decreased by Runx1 inhibition with transfection of Runx1 siRNA to DRG neurons in early developing chick embryos (Marmigère et al., 2006) . There seems to be some discrepancy in the effects of Runx1 inactivation on TrkA expression in previous reports. It was reported that Runx1 inactivation reduces of TrkA + neuronal number in early chick DRG and in early developing mouse trigeminal ganglion (Theriault et al., 2004; Marmigère et al., 2006) . In contrast, we and Chen et al. reported that Runx1 inactivation increases TrkA + neurons in mouse DRG at late embryonic and postnatal stages (Chen et al., 2006b; Yoshikawa et al., 2007) . The present study showed that Runx1 inactivation reduces TrkA + neurons at the early embryonic period, in contrast to the increase of TrkA + neurons at late embryonic stage in the same mouse strain (Yoshikawa et al., 2007) .
Therefore, it is possible the discrepancy regarding the Runx1 function in TrkA expression may be due to the differences of the developmental stages examined.
It was reported that Runx1 promotes the cell proliferation of ORN precursors in the olfactory epithelium (Theriault et al., 2005) . In contrast, the present study showed the opposite function of Runx1 in suppression of the proliferation of DRG cells. In the olfactory epithelium, Runx1 is expressed in proliferating cells (Theriault et al., 2004) . By contrast, in DRG, Runx1 is expressed in post-mitotic cells undergoing neuronal differentiation but not proliferating cells (Chen et al., 2006b; Marmigère et al., 2006; Yoshikawa et al., 2007 , Fig.   S1 ). Therefore, it is likely that Runx1 is different in the expression between proliferating ORN precursors and postmitotic DRG neurons and that Runx1 has different functions between these cells.
Possible involvement of Hes1 in mediating the effects of Runx1 in the neuronal differentiation
The present study suggested that Runx1 promotes the differentiation of DRG neurons. To gain an insight into the molecular mechanisms mediating actions of Runx1 in the neuronal differentiation, we examined the expression of Hes1 which has been shown to suppress neuronal differentiation (Cau et al., 2000; Ishibashi et al., 1995; Iso et al., 2003; Guo et al., 2008; Tomita et al., 1996) . In Runx1 -/-::Tg DRG, Hes1 + cells were increased, suggesting the possibility that the promotion of neuronal differentiation by Runx1 is mediated by the suppression of Hes1 expression. However, the regulatory mechanisms of Hes1 expression by Runx1 remain to be examined. It is possible that Runx1 + DRG neurons themselves do not express Hes1 and suppress Hes1 expression in cells undergoing neuronal differentiation which adjoin the Runx1 + DRG neurons (Fig. 8A) . Alternatively, Runx1 suppresses Hes1 expression cell-autonomously within the same cells (Fig. 8B) . The first regulatory mechanism seems to be plausible in DRG, considering the previous study showing that Runx1 is expressed in postmitotic (therefore Hes1-negative or weakly positive) DRG neurons.
However, we could not exclude the second possibility that Hes1 is downstream to Runx1. In various types of cells including the olfactory epithelial cells, it has been shown that Runx1 cofactor CBF-1 is involved in the regulation of Hes1 expression (Cau et al., 2000; Guo et al., 2008; Ishibashi et al., Iso et al., 2003; Tomita et al., 1996) .
To determine the mechanisms of the regulation of Hes1 expression by Runx1, we examined the co-localization of Runx1 and Hes1. In summary, the present study suggested novel functions of Runx1 in the regulation of proliferation and neuronal differentiation of DRG neurons during the early stage of the development. Although the suppression of Hes1 expression may be involved in the promotion of neuronal differentiation by Runx1, further studies are needed to clarify the regulatory mechanisms.
Experimental Methods
Animal maintenance and genotyping
The strategy used to inactivate Runx1 in the mouse germline and rescue Runx1 gene knockout mice from embryonic lethality by expressing the Runx1 transgene in erythroid cells specifically was described previously (Okada et al., 1998; Okuda et al., 1996; Yokomizo et al., 2007 , Yoshikawa et al., 2007 were obtained by overnight mating, and the morning when the vaginal plug was observed was considered E0.5. The stages of mouse embryos were confirmed according to Kaufman (Kaufman, 1992) . Runx1 mutant mice were genotyped using PCR as described previously (Okada et al., 1998 ) and a pair of primers, RUNT S1
(5'-AGCATGGTGGAGGTACTAGC-3') and RUNT AS1
(5'-GGTCGTTGAATCTCGCTACC-3') was used for Runx1 transgene detection. All experiments followed the Guide for the Care and Use of Laboratory Animals described by the National Institutes of Health (USA) and were approved by the Animal Experimentation
Committee of the University of Tsukuba.
Immunohistochemistry
For cryostat sections, E11.5 and E12.5 whole mouse embryos were immersed two overnights, and E13.5 were immersed overnight at 4˚C in a fixative containing 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). Whole mouse embryos were immersed in 0.1 M PB containing 20% sucrose overnight on ice and frozen in Tissue-Tek O. C. T. compound (Sakura Finetek, Japan). Ten m transverse serial sections of the trunk at thoracic segments were cut using a cryostat (HM 500 OM; Microm, Germany) and collected onto MAS-coated glass slides (Matsunami Glass, Japan) and air-dried for 1 h. If needed, sections were subjected to heat-induced epitope retrieval by heating to 105˚C for 8 min in Dako REAL TM Target Retrieval Solution (Dako). After treatment for 30 min at room temperature (RT) with 0.3% H2O2 in methanol to eliminate endogenous peroxidase reaction, the sections were incubated for 1 h at RT in a blocking solution containing 5% normal goat serum or 5% normal horse serum and 0.15% Triton X-100 in phosphate-buffered saline.
For immunohistochemical analysis, the following specific antibodies were used: mouse 
Cell cycle analysis
Cell cycle analysis was based on a previous paper (Martynoga et al., 2005) . To estimate the cell cycle parameters; the number of S-phase and G2/M-phase cells and the length of S-phase, pregnant female mice 12.5 days after mating were injected intraperitoneally with 5'-Indo-2'-deoxyuridine (IDU, Sigma, 50 mg/kg) at T = 0 h to label all cells in S-phase at start of the experiment (Fig. 5A ). At T = 1.5 h, 5'-Bromo-2'-deoxyuridine (BrdU, Sigma, 50 mg/kg) was injected and the embryos were fixed after 0.5 h, sufficient to label the S-phase cells at the end of the labeling period (Nowakowski et al., 1989) . During the 1. 
Cell counting, Measurement of DRG volume and statistical analysis
DRGs at thoracic segments were serially sectioned at 10 m, and all the sections containing a particular DRG were immunostained by a single antibody and used for cell counting. with a CCD camera on an Axioplan2 microscope (Carl Zeiss) or an LSM510META confocal microscope (Carl Zeiss) using a 20x objective. As described previously (Nakamura et al., 2008) , cells were counted if they contained a nucleus and had a signal intensity in the cytoplasm or nucleus that was more than 2.5-fold above the noise level for that tissue section.
For measurement of DRG volume, 10 m-thick serial sections containing whole DRGs (Th11) at E12.5 were used. The DRG areas in each section were measured and the DRG volume calculated using ImageJ image analysis software (NIH). Quantitative analyses were performed on three pairs of embryos from three independent pregnant mice. Statistical analyses were performed using the F test, followed by the Student's t test. Differences were considered significant if the probability of error was less than 5%. All results are expressed as the mean ±SEM. 
